Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Jun 25, 2017 | $24.7B |
| FY2018, ended Jun 24, 2018 | $27.5B |
| FY2019, ended Jun 30, 2019 | $27.1B |
| FY2020, ended Jun 28, 2020 | $44.1B |
| FY2021, ended Jun 27, 2021 | $89.5B |
| FY2022, ended Jun 26, 2022 | $61.7B |
| FY2023, ended Jun 25, 2023 | $80.7B |
| FY2024, ended Jun 30, 2024 | $138B |
| FY2025, ended Jun 29, 2025 | $123B |
| FY2026, ended Jun 28, 2026 | $474B |
| Trailing 12 months to Sep 27, 2026 (through Q1 FY2027) | $394B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Jun 25, 2017 | $8.01B |
| FY2018, ended Jun 24, 2018 | $11.1B |
| FY2019, ended Jun 30, 2019 | $9.65B |
| FY2020, ended Jun 28, 2020 | $10.0B |
| FY2021, ended Jun 27, 2021 | $14.6B |
| FY2022, ended Jun 26, 2022 | $17.2B |
| FY2023, ended Jun 25, 2023 | $17.4B |
| FY2024, ended Jun 30, 2024 | $14.9B |
| FY2025, ended Jun 29, 2025 | $18.4B |
| FY2026, ended Jun 28, 2026 | $23.2B |
| Trailing 12 months to Sep 27, 2026 (through Q1 FY2027) | $26.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Jun 25, 2017 | $1.70B | $1.87B |
| FY2018, ended Jun 24, 2018 | $2.38B | $2.38B |
| FY2019, ended Jun 30, 2019 | $2.19B | $2.87B |
| FY2020, ended Jun 28, 2020 | $2.25B | $1.92B |
| FY2021, ended Jun 27, 2021 | $3.91B | $3.24B |
| FY2022, ended Jun 26, 2022 | $4.61B | $2.55B |
| FY2023, ended Jun 25, 2023 | $4.51B | $4.68B |
| FY2024, ended Jun 30, 2024 | $3.83B | $4.26B |
| FY2025, ended Jun 29, 2025 | $5.36B | $5.41B |
| FY2026, ended Jun 28, 2026 | $7.27B | $4.89B |
| Trailing 12 months to Sep 27, 2026 (through Q1 FY2027) | $8.45B | $6.54B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Jun 25, 2017 | $2.38B |
| FY2018, ended Jun 24, 2018 | $4.51B |
| FY2019, ended Jun 30, 2019 | $3.66B |
| FY2020, ended Jun 28, 2020 | $4.92B |
| FY2021, ended Jun 27, 2021 | $4.42B |
| FY2022, ended Jun 26, 2022 | $3.52B |
| FY2023, ended Jun 25, 2023 | $5.34B |
| FY2024, ended Jun 30, 2024 | $5.85B |
| FY2025, ended Jun 29, 2025 | $6.39B |
| FY2026, ended Jun 28, 2026 | $5.58B |
| Trailing 12 months to Sep 27, 2026 (through Q1 FY2027) | $7.44B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Jun 25, 2017 | $2.69B |
| FY2018, ended Jun 24, 2018 | $2.37B |
| FY2019, ended Jun 30, 2019 | $4.43B |
| FY2020, ended Jun 28, 2020 | $5.80B |
| FY2021, ended Jun 27, 2021 | $4.96B |
| FY2022, ended Jun 26, 2022 | $4.96B |
| FY2023, ended Jun 25, 2023 | $4.97B |
| FY2024, ended Jun 30, 2024 | $4.97B |
| FY2025, ended Jun 29, 2025 | $4.47B |
| FY2026, ended Jun 28, 2026 | $3.72B |
| Trailing 12 months to Sep 27, 2026 (through Q1 FY2027) | $3.74B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 23.1% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Jun 25, 2017 | 1.62B |
| FY2018, ended Jun 24, 2018 | 1.58B |
| FY2019, ended Jun 30, 2019 | 1.45B |
| FY2020, ended Jun 28, 2020 | 1.46B |
| FY2021, ended Jun 27, 2021 | 1.42B |
| FY2022, ended Jun 26, 2022 | 1.37B |
| FY2023, ended Jun 25, 2023 | 1.33B |
| FY2024, ended Jun 30, 2024 | 1.30B |
| FY2025, ended Jun 29, 2025 | 1.27B |
| FY2026, ended Jun 28, 2026 | 1.25B |
| Trailing 12 months to Sep 27, 2026 (through Q1 FY2027) | 1.25B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2017, ended Jun 25, 2017 | $812M | $150M | $12.9M |
| FY2018, ended Jun 24, 2018 | $2.65B | $172M | $9.26M |
| FY2019, ended Jun 30, 2019 | $3.78B | $187M | $6.81M |
| FY2020, ended Jun 28, 2020 | $1.37B | $189M | $8.08M |
| FY2021, ended Jun 27, 2021 | $2.70B | $220M | $24.1M |
| FY2022, ended Jun 26, 2022 | $3.87B | $259M | $5.68M |
| FY2023, ended Jun 25, 2023 | $2.02B | $287M | $11.1M |
| FY2024, ended Jun 30, 2024 | $2.84B | $293M | $15.6M |
| FY2025, ended Jun 29, 2025 | $3.42B | $343M | $2.45M |
| FY2026, ended Jun 28, 2026 | $3.85B | $386M | $17.4M |
| Trailing 12 months to Sep 27, 2026 (through Q1 FY2027) | $3.90B | $404M | $21.7M |
Valuation
At current price- Market Cap
- $301B
- P/E
- 35.6×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 11.5×
- Price / Book
- 21.6×
- EV / EBITDA
- 29.4×
Growth
Trailing 12 months- Revenue (TTM)
- $26.1B
- Revenue Growth YoY
- 33.4%
- Revenue CAGR 3Y
- 10.1%
- Revenue CAGR 5Y
- 9.7%
- EPS Growth YoY
- 48.1%
- Net Income Growth YoY
- 45.4%
Profitability
Trailing 12 months- Gross Margin
- 51.1%
- Operating Margin
- 37.0%
- Net Margin
- 32.3%
- FCF Margin
- 25.0%
- Return on Equity
- 70.1%
Earnings
Trailing 12 months- Net Income
- $8.45B
- EPS (diluted)
- $6.71
- EBITDA
- $10.1B
- Operating Income
- $9.65B
Balance Sheet
As of Sep 27, 2026- Cash and cash equivalents
- $7.44B
- Total Debt
- $3.74B
- Net Cash
- $3.70B
- Total Assets
- $26.4B
- Total Liabilities
- $12.4B
- Shareholders' Equity
- $13.9B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $7.58B
- Capital Expenditure
- $1.04B
- Free Cash Flow
- $6.54B
Dividends and risk
Last 12 months- Dividend Yield
- 0.5%
- Dividend / Share
- $1.11
- Beta (5Y)
- 1.84
Every ratio is calculated from the company’s reported figures.